tag@treatmentactiongroup.org

U.S.

TAG Statement: OMB Proposal Would Turn Federal Grants Into a Political Tool

  • Adam Ortega

The White House Office Of Management and Budget (OMB) under the direction of Russell Vought is seeking a regulatory blessing to use Federal grant funding as a tool for political extortion, violation of due process, and further undermining of scientific integrity. Targets include scientists, institutions, organizations, States, cities, and other recipients who might fail an extreme right wing, Christian nationalist, anti-science political litmus test. 

Read more

The Cure Hep C Act: How exclusions may undermine elimination

  • Adam Ortega

The United States is currently at an inflection point in Hepatitis C virus (HCV) response. We have the tools for rapid and accurate diagnosis, safe and effective cure, and prevention. These tools are only as useful as access to them can be, which is why the Cure Hepatitis C Act (S.1941) holds so much promise.

Read more

Message from TAG Executive Director Mark Harrington: 45 Years Later, We Cannot Afford Inaction

  • Adam Ortega

Forty-five years ago the Centers for Disease Control and Prevention (CDC) published a brief report describing five cases of a rare pneumonia among young gay men in Los Angeles. The report occupied just a few paragraphs in the Morbidity and Mortality Weekly Report (MMWR). No one reading it could have known that it marked the beginning of one of the deadliest epidemics in modern history.

Read more

Financing Health Equity

  • Adam Ortega

The Promise and Potential of Economic Reforms for Health The collapse of global health aid in 2025 revealed the fragility of health financing. Despite successes against TB and HIV in recent years, health aid from bilateral and multilateral donors has…

Read more

TAG Executive Director Mark Harrington Receives Wakefield HVTN Award

  • Adam Ortega

Huge congratulations to TAG’s Executive Director Mark Harrington for winning a Wakefield Outstanding Dedication Award presented by the HIV Trials Network (HVTN)! The HVTN, the largest publicly funded collaboration facilitating HIV/AIDS vaccine evaluations, presents the Wakefield Award to public health champions who demonstrate exceptional service and contribution to HIV vaccine research.

Read more

TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks

  • Adam Ortega

TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.

Read more

Near Point-of-Care TB Tests: What Communities Need to Know and Advocate for in Global Fund Grant Cycle 8

  • Adam Ortega

TB testing is getting faster, cheaper, and more accessible and advocates have a critical window to act. Treatment Action Group's new factsheet breaks down WHO-recommended near point-of-care TB tests and shows how communities can use Global Fund Grant Cycle 8 to finance their rollout. With an estimated 2.7 million people going undiagnosed in 2024 alone, the tools and funding are finally aligned. Now is the time to push for change.

Read more
Back To Top